CIK 0001411685
- Non-accelerated filer
- Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 205093315
- Phone
- +1 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-09 | Cunningham Ann Michelle Director | Grant or award · Non-Qualified Stock Option (right to buy) | +17,600 | 17,600 | ||
| 2024-09-06 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +14,100 | 14,100 | ||
| 2024-03-04 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2022-03-01 | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-05-01 | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2020-12-30 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-04-23 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-10-21 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-05-23 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-01-10 | Cunningham Ann Michelle Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 1 of 1 · 10 trades